Last reviewed · How we verify

NCT03720301

The Use of Osteopathic Medical Manipulation to Decrease the Incidence and Severity of Post-Operative Sore Throat

Status unknown NA Last updated 25 October 2018
What this trial tests

NA trial testing Osteopathic Manipulation Treatment in Pharyngitis in 168 participants. Status unknown.

Timeline
17 October 2018
Primary endpoint
30 June 2020
30 June 2020

Quick facts

Lead sponsorBrooke Army Medical Center
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeprevention
Enrollment168
Start date17 October 2018
Primary completion30 June 2020
Estimated completion30 June 2020
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Brooke Army Medical Center

Who can join

18 and older, any sex, with Pharyngitis or Dysphonia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Post-operative sore throat (POST) ranks as the 8th most undesirable effect in the post-operative period and is noted by up to 90% of patients receiving an endotracheal tube. \[1-3\] This study aims to show that a simple 5 minute preoperative and intraoperative osteopathic medical manipulation protocol can decrease the severity and or the incidence of post-operative sore throat thereby decreasing morbidity and increasing patient satisfaction and return to daily life.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Osteopathic Manipulation Treatment

Trials testing the same drug.

Other recruiting trials for Pharyngitis

Currently open trials in the same condition.

Other Brooke Army Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03720301.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing